2017•International Journal of Antimicrobial AgentsOpen access

Decreased tacrolimus plasma concentrations during HCV therapy: a drug–drug interaction or is there an alternative explanation?

Elise J. Smolders, Simon Pape, Clara T. M. M. de Kanter, A. P. van den Berg, Joost P.H. Drenth, David M. Burger

Open full text 21 citations

Abstract

This record does not include an abstract. Use the full-text link above if available.

About this research paper

What this paper is about

An abstract is not available in the OpenAlex record for this paper.

Why it matters

OpenAlex reports 21 citations for this work. Citation counts describe recorded attention and do not establish research quality.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Key concepts: Tacrolimus, Medicine, Liver transplantation, Pharmacology, Hepatitis C virus, Drug interaction, Pharmacokinetics, Drug

Back to paper search Browse research topics Original source

Decreased tacrolimus plasma concentrations during HCV therapy: a drug–drug interaction or is there an alternative explanation? — Research Paper | ScholarLens